The protective effect of L-carnitine on ischemia-reperfusion heart

Abstract

To investigate the protective effect of L-carnitine on myocardial ischemia-reperfusion injury in rat heart, all harvested isolated hearts were perfused on Langendorff apparatus with oxygenized K-H solution for 20 min. The hearts were then exposed to ischemia for 30 min. Following the ischemia the hearts were re-perfused with K-H solution for 120 min to serve as the control group A. Either 5 or 10 mmol/L of L-carnitine was added into the K-H solution for 20 min at the beginning of reperfusion to generate group B and group C, respectively. The derivatives of the intraventricular pressure curve (DP/DT), left ventricular developed pressure (LVDP), and coronary flux were monitored during the entire experiment. The levels of ATP, hepatin, malondialdehyde (MDA), and superoxide dismutase (SOD) in tissue, and lactic dehydrogenase (LDH), creatine phosphate kinase (CPK), malondialdehyde (MDA), and superoxide dismutase (SOD) concentration in the coronary efflux were all measured. Compared with the control group, the treatment with L-carnitine resulted in better results, i. e., higher DP/DT_max and LVDP. At the same time, ventricular fibrillation was reduced, and the levels of ATP, hepatin and SOD were all elevated. However, the concentrations of MDA, CPK and LDH were all reduced. In conclusion, L-carnitine has a protective effect on ischemia-reperfusion injury, which is partly due to its prevention of energy loss and its antioxidant activity.

Keywords

L-carnitine / ischemia-reperfusion injury / ATP / antioxidant activity

References

[1] CuiJ, DasD K, BertelliA, et al. . Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem, 2003, 254: 227-227

[2] LosterH, KellerT, GrommischJ, et al. . Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy. Mol Cell Biochem, 1999, 200: 93-93

[3] CalvaniM, RedaE, Arrigoni-MartelliE, et al. . Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol, 2000, 95: 75-83

[4] HwangY C, BakrS, RamasamyR, et al. . Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium. Coron Artery Dis, 2002, 13: 313-318

[5] CarvajalK, Moreno-SanchezR, et al. . Heart metabolic disturbances in cardiovascular diseases. Arch Med Res, 2003, 34: 89-99

[6] BroderickT L, CifuentesJ, GreenD, et al. . Short-term carnitine deficiency recovery after ischemia. Can J Physiol Pharmacol, 2001, 79: 892-897

[7] CamH, YildirimB, AydinA, et al. . Carnitine levels in nconatal hypoxia. Trop Pediatr, 2005, 51(2): 106-108

[8] MamoulakisD, GalanakisE, DionyssopoulouE, et al. . Carnitine deficiency in children and adolescents with type 1 diabetes. J Diabetes Complications, 2004, 18(5): 271-274

[9] LosterH, BohmU. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions. Mol Cell Biochem, 2001, 217: 83-90

[10] HuJ Q, DingH J. Protective effect of L-propionylcarnitine on myocardial injury induced by ischemia and reperfusion and its antiradical effects. Acad J Sec Mil Med Univ (Chinese), 1997, 18: 41-44

[11] IratA M, AktanF, OzansoyG, et al. . Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. Pharm pharmacol (Chinese), 2003, 55: 1389-1395

[12] ZhouC L, DuanR F, XinS L, et al. . Effects of L-carnitine on superoxide dismutase and malondialdehyde levels in patients with congestive heart failure. Acad J Sec Mil Med Univ (Chinese), 2003, 24: 916-917